KSE-listed pharmaceutical firms showing strong 3-quarter results
KSE (Korea Stock Exchange)-listed pharmaceutical firms in the first nine months of this year continued to post robust sales of 2.4 trillion won, up 14.5 percent compared with 2.1 trillion won from a year earlier, according data released by Yakup Shinmoon.
The data showed that except for ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
